Abstract
COVID-19 outbreaks have had high mortality in low- and medium-income countries such as Ecuador. Human mobility is an important factor influencing the spread of diseases possibly leading to a high burden of disease at the country level. Drastic control measures, such as complete lockdown are effective epidemic controls, yet in practice, one hopes that a partial shutdown would suffice. It is an open problem to determine how much mobility can be allowed while controlling an outbreak. In this paper, we use statistical models to relate human mobility to the excess death in Ecuador while controlling for demographic factors. The mobility index provided by GRANDATA, based on mobile phone users, represents the change of number of out-of-home events with respect to a benchmark date (March 2nd, the first date the data is available). The study confirms the global trend that more men are dying than expected compared to women, and that people under 30 show less deaths than expected. Specifically, individuals in the age groups younger than 20, we found have their death rate reduced during the pandemic between 22% and 27% of the expected deaths in the absence of COVID-19. The weekly median mobility time series shows a sharp decrease in human mobility immediately after a national lockdown was declared on March 17, 2020 and a progressive increase towards the pre-lockdown level within two months. Relating median mobility to excess death shows a lag in its effect: first, a decrease in mobility in the previous two to three weeks decreases the excess death and more novel, we found that an increase of mobility variability four weeks prior, increases the number of excess deaths.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work is partially funded by the Laboratory Directed Research and Development (LDRD) Rapid Response Program through the Center for Nonlinear Studies at Los Alamos National Laboratory, and LDRD grants 20200699ER and 20210709ER. RK and SP would like to acknowledge funding from DARPA (HR0011938513), the Center for Nonlinear Studies. ERS was funded though NIH grant (R01AI135946). LC and NH would also like to acknowledge the US Department of Energy Office of Science through the National Virtual Biotechnology Laboratory, a consortium of national laboratories (Argonne, Los Alamos, Oak Ridge, and Sandia) focused on responding to COVID-19, with funding provided by the Coronavirus CARES Act. The funding source had no role in the design of the study, execution, analyses, interpretation of the data, or decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee approval for the use of health patient information and death records was obtained from the Comite de Etica de Revision Expedita de Investigaciones COVID-19 (Ethical Committee for Expedited Review of COVID-19 Research) of the Ecuadorian Ministry of Health. The study, including the use of mobility data, has been approved by the Human Subjects Research Review Board, Los Alamos National Laboratory.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying this article cannot be shared publicly due to Ecuador government regulations that the Ecuadorian Ministry of Public Health must approve the research protocol to release reusable COVID-19 datasets. Vital statistics may be available upon request to the Ecuadorian Civil Registry and will be publicly available through the Institute of Statistics and Census according to its statistics calendar. Mobility data used in this paper were provided by the United Nations Development Program (UNDP) and GRANDATA, under the umbrella of UNDP's call for papers "Exploring impact and response to the COVID-19 pandemic in Latin America and the Caribbean using mobility data", to promote policy-oriented research on the COVID-19 pandemic effects in LAC. Findings, interpretations, and conclusions are from the authors and do not necessarily represent UNDP's views. The data may be shared upon reasonable request to the corresponding authors.
